Indaptus Therapeutics Inc. - Common Stock, $0.01 par value (INDP)

CUSIP: 45339J105

Q4 2021 13F Holders as of 31 Dec 2021

Type / Class
Equity / Common Stock, $0.01 par value
Shares outstanding
113,265,306
Total 13F shares
1,836,196
Share change
+1,294,401
Total reported value
$10,466,000
Price per share
$5.70
Number of holders
11
Value change
+$6,508,484
Number of buys
9
Number of sells
3

Quarterly Holders Quick Answers

What is CUSIP 45339J105?
CUSIP 45339J105 identifies INDP - Indaptus Therapeutics Inc. - Common Stock, $0.01 par value in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Indaptus Therapeutics Inc. - Common Stock, $0.01 par value (INDP) as of Q4 2021

As of 31 Dec 2021, Indaptus Therapeutics Inc. - Common Stock, $0.01 par value (INDP) was held by 11 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 1,836,196 shares. The largest 10 holders included Stratos Wealth Partners, LTD., VANGUARD GROUP INC, INVESTMENT HOUSE LLC, GEODE CAPITAL MANAGEMENT, LLC, MILLENNIUM MANAGEMENT LLC, UNITED CAPITAL FINANCIAL ADVISERS, LLC, UBS Group AG, Harel Insurance Investments & Financial Services Ltd., MORGAN STANLEY, and NATIONAL BANK OF CANADA /FI/. This page lists 11 institutional shareholders reporting positions in this security for the Q4 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.